Chiesi Usa, Inc.: Cleviprex (clevidipine Injectable Emulsion) 50 Mg/100 Ml (0.5 Mg/ml), 10 Single Use Vials

CLEVIPREX Recall Summary Chiesi USA is recalling CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL vials nationwide because the manufacturer cannot guarantee the product is sterile. CLEVIPREX is a prescription injectable medication used to lower blood pressure. The recall affects vials distributed across all U.S. states.

Recalling firm
Chiesi USA, Inc.
Product
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
Reason
Lack of Assurance of Sterility
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-07-06
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
Nationwide within the United States

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/9f449d9c-0d0c-45ac-acff-5531c84f380b